CD66b+ Neutrophils and Α-Sma+ Fibroblasts Predict Clinical Outcomes and Benefits From Postoperative Chemotherapy in Gastric Adenocarcinoma

Cancer Medicine - United Kingdom
doi 10.1002/cam4.2939

Related search